Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy
John Nemunaitis
· 2024-08-05
Links
DOI
PubMed
Journal
Future Oncology
Institutions
Gradalis United States
Authors
John Nemunaitis